Goldstream Capital Management LTD Intellia Therapeutics, Inc. Transaction History

Goldstream Capital Management LTD

  • $297 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 19, 2022
BUY
$53.92 - $71.7 $242,640 - $322,650
4,500 Added 112.5%
8,500 $476,000
Q2 2022

Jul 25, 2022
BUY
$38.49 - $76.21 $153,960 - $304,840
4,000 New
4,000 $207,000
Q1 2022

May 13, 2022
SELL
$58.27 - $118.99 $1.76 Million - $3.59 Million
-30,161 Closed
0 $0
Q4 2021

Feb 11, 2022
BUY
$100.76 - $138.36 $3.04 Million - $4.17 Million
30,161 New
30,161 $3.57 Million

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $775M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Goldstream Capital Management LTD Portfolio

Follow Goldstream Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldstream Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Goldstream Capital Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email